Science Explorer Back to mapMap
Discussion
Company · Nantes · France

ATLAB Pharma (France)

atlab-pharma.comROR OpenAlex
Research works
1
fractional, all time
Citations
47
72.3 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
Open access
69%
world 40%
International
69%
world 18%
ATLAB Pharma (France)

Not ranked overall: ATLAB Pharma (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ATLAB Pharma (France) work in?

In all years, 50% of research at ATLAB Pharma (France) is in Life Sciences, 50% in Health Sciences. Its largest fields are Medicine (50%), Immunology and Microbiology (33%), Biochemistry, Genetics and Molecular Biology (17%).

Life Sciences: 0 fractional works · 50.0% of its workImmunology and Microbiology: 0 fractional works · 33.3% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 16.7% of its workHealth Sciences: 0 fractional works · 50.0% of its workMedicine: 0 fractional works · 50.0% of its workALL ITS WORKATLAB Pharma(France)1fractional works, all years
Life Sciences50%Health Sciences50%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 3 fields, with their numbers
    1. Immunology and Microbiology033.3%
    2. Biochemistry, Genetics and Molecular Biology016.7%
    1. Medicine050.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Which research topics does ATLAB Pharma (France) publish most on?

By volume in 2022-now: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research and Immune Cell Function and Interaction.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 0 works
  2. 2 CAR-T cell therapy research Oncology 0 works
  3. 3 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available69.4%not open30.6%

World: 40% of research is openly available.

with international co-authors69.4%domestic only30.6%

World: 18% is written across borders.

How has ATLAB Pharma (France)'s research output changed?

still counting201520202025

Other research institutions in Nantes

All research institutions in Nantes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ATLAB Pharma (France). Posts are plain text and can be reported.